The Role of MMP7 and Its Cross-Talk with the FAS/FASL System during the Acquisition of Chemoresistance to Oxaliplatin
Vanessa Almendro, Elisabet Ametller, Susana García-Recio et al. · 2009
Read The Role of MMP7 and Its Cross-Talk with the FAS/FASL System during the Acquisition of Chemoresistance to Oxaliplatin by Vanessa Almendro, Elisabet Ametller, Susana García-Recio et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004728.txt.
Description
Vanessa Almendro and colleagues studied how a cutting enzyme helps cancer cells resist a chemo drug, in PLOS ONE in 2009. The drug oxaliplatin works less well once tumors learn to resist it. The enzyme MMP7 has been tied to that loss of response, though the exact route was not fully clear.
MMP7 levels also predict outlook on their own in some cancers. The team traced cross talk between MMP7 and a death signal system in the cells. Their work suggests the enzyme helps cells dodge drug induced death. Blocking that help could restore drug response in some tumors.
Catalog record
| CREATOR | Vanessa Almendro, Elisabet Ametller, Susana García-Recio et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004728